
Victoria Nachar
@victorianachar
Hematology Clinical Pharmacist @UMRogelCancer 〽️#GoBills #Buffalove
ID: 326455500
29-06-2011 23:13:35
1,1K Tweet
452 Followers
275 Following

I’m excited to introduce our brand new hematology podcast – WolverHeme Happy Hour (@wolverheme anchor.fm/wolverheme)! Grab your favorite drink🍻and listen to me, Anthony Perissinotti, and friends nerd out about heme data! open.spotify.com/show/3VDDwc3BE… #TwitteRx #WolverHeme

Episode 9: "ASH Recap Part 1 - Dauno-Double Trouble" is out! Should this trial change practice? Is Dauno 90 really dead? Our discussion might surprise you! #leusm #twitterx #teambadblood Bernie Marini Anthony Perissinotti anchor.fm/wolverheme/epi…

Swipe right, and listen to Episode 12 "Tinder for T Cells - Bispecifics in DLBCL" by WolverHeme Happy Hour. We are joined by special guest Lymphoma Experts Victoria Nachar and Tycel Phillips! Bernie Marini Anthony Perissinotti anchor.fm/wolverheme/epi…

What’s cooler than being cool? Being Maddy Ochs that’s what! Great talk on cold agglutinin disease by the rockstar Maddy Ochs #HOPAAC23


The Taylor swift references - incredible. Literally 10/10. Chefs kiss. 🤌Anthony Perissinotti Bernie Marini Maddy Ochs Justin Arnall

Dual target dilemma lead by the incredible James Davis, PharmD, BCOP

Great Peer Exchange with an amazing group on myelofibrosis with James Davis, PharmD, BCOP Zahra M, PharmD, MBA, BCOP, FHOPA Victoria Nachar and Shawn Griffin pharmacytimes.com/view/myelofibr…

Managed care professionals looking to stay updated on the latest in #myelofibrosiscare. Join our CPE-certified webinar with Victoria Nachar, Justin Arnall. Learn about treatment advances & pharmacist roles in patient care. 👉 Add it to your calendar: proce.com/events/pharmac…


Check out our latest episode "Myeloma Madness with the Myeloma Man", where Anthony Perissinotti and Bernie Marini discuss the recent FDA approval updates on CAR-T in myeloma with our good friend and myeloma expert Manni Mohyuddin podcasters.spotify.com/pod/show/wolve…


Bispecific antibodies are changing treatment in Hem/Onc.. but adoption has been mixed due to logistics! Out now in JADPRO, we aim to tackle some FAQ! 🙏🏻 to Amir Ali, PharmD, BCOP James Davis, PharmD, BCOP Tyler Sandahl Victoria Nachar Robert Mancini, PharmD, BCOP, FHOPA! #oncopharm #TwitterRx jadpro.com/online-first/2…

Time for a MANTLE CELL MASTERCLASS with Tycel Phillips Anthony Perissinotti and Bernie Marini ! Should TRIANGLE change the SOC? Where do bispecifics and CAR-T fit into the treatment paradigm? Listen and find out! #lymsm #twitterx podcasters.spotify.com/pod/show/wolve…

How do you treat low grade CRS due to myeloma bispecifics? We investigated differences of using dexamethasone and toci in CRS with teclistamab in six US centers and found as few as one 10mg dex dose is enough to alleviate low grade CRS. #ASH24 Victoria Nachar Zahra M, PharmD, MBA, BCOP, FHOPA Jordan Snyder



🌶️Hot off the press! 🌶️ Dexamethasone for CRS with teclistamab. You don't need toci for grade 1 CRS! great team work - Victoria Nachar CharlotteBWagner Zahra M, PharmD, MBA, BCOP, FHOPA Kelley Louise Julian, PharmD, BCOP Mikhaila Rice Katelynn Granger, PharmD, BCOP Jack Khouri nature.com/articles/s4140…


Myeloma Paper of the Day, March 5th, suggested by Robert Orlowski (Robert Z. Orlowski) Victoria Nachar Zahra M, PharmD, MBA, BCOP, FHOPA oncodaily.com/science/myelom… #MyelomaPaperoftheDay #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews

📘 Dive into BCMA-directed therapies for MM and strengthen your treatment approach with new data! 📍 Oregon Convention Center, 777 NE Martin Luther King Jr Blvd, Room B113-114 📢 Learn more: ms.spr.ly/6016qSSUy Join 👉 Kirollos Hanna Victoria Nachar Jared Matya #HOPA2025


Check out are latest episode, with a star-studded cast! 🤩 "Dex and the Cytokine City: Managing CRS with Bispecifics" #leusm #lymsm #myeloma #TwitteRx @berninini James Davis, PharmD, BCOP Victoria Nachar Anthony Perissinotti Justine Preedit creators.spotify.com/pod/show/wolve…

Me, in my car. Well done WolverHeme